Evidence map›Paper›PMID 41928462›Full record

ArticleTechnology in cancer research & treatment

Value Analysis of MRI Habitat Analysis Combined Model in the Diagnosis of Ovarian Tumors.

Junying Wang, Kang Liu, Yan Sui, Siyu Ma, Dewu Yang

Abstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Junying WangDepartment of Medical Technique, Beijing Health Vocational College, Beijing, China.
Kang LiuDepartment of Radiology, Fuxing Hospital Affiliated With Capital Medical University, Beijing, China.
Yan SuiDepartment of Radiology, Fuxing Hospital Affiliated With Capital Medical University, Beijing, China.
Siyu MaDepartment of Medical Technique, Beijing Health Vocational College, Beijing, China.
Dewu YangDepartment of Medical Technique, Beijing Health Vocational College, Beijing, China.ORCID 0000-0003-3867-2649

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectiveThis study aimed to investigate the clinical diagnostic performance of a combined classification model incorporating magnetic resonance imaging (T1WI-CE) habitat and human epididymis protein 4 (HE4) for differentiating borderline ovarian tumors (BOTs) from malignant epithelial ovarian tumors (MEOTs).MethodsA retrospective analysis was conducted on 127 patients with pathologically confirmed ovarian tumors, including 62 with BOTs and 65 with MEOTs, all of whom underwent preoperative magnetic resonance imaging examination. Twenty habitat features, including the original images, were extracted. T1WI-CE was used to extract 2395 radiomics features from two habitat subregions. Feature selection was performed using correlation analysis and least absolute shrinkage and selection operator regression.ResultsThe combined classification model had the highest area under the curve, 0.941 in the training group and 0.880 in the test group, thus outperforming the habitat area and clinical data classification model. The DeLong test demonstrated statistically significant differences between the combined classification model and the clinical classification model, with

Indexed as

Magnetic Resonance ImagingOvarian NeoplasmsAdultAgedBiomarkers, TumorFemaleHumansMiddle AgedRadiomicsRetrospective StudiesROC CurveBiomarkers, Tumorborderline–malignant differentiationserum tumor markerT1-weighted contrast-enhanced magnetic resonancetumor heterogeneity

Identifiers

PMID41928462
PMCPMC13051162

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.